カテゴリー： 世界, 医療/バイオ, LP Information

世界のブルートン型チロシンキナーゼ（BTK）阻害剤市場予測 2023年-2029年

【英語タイトル】Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC06286）・商品コード：LP23DC06286
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：108
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のブルートン型チロシンキナーゼ（BTK）阻害剤市場」は、過去の販売実績から2022年の世界のブルートン型チロシンキナーゼ（BTK）阻害剤の総販売量を検討し、2023年から2029年の予測されるブルートン型チロシンキナーゼ（BTK）阻害剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のブルートン型チロシンキナーゼ（BTK）阻害剤の市場規模を掲載し、XXX百万米ドル規模の世界のブルートン型チロシンキナーゼ（BTK）阻害剤市場の詳細な分析を提供します。本インサイトレポートは、世界のブルートン型チロシンキナーゼ（BTK）阻害剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のブルートン型チロシンキナーゼ（BTK）阻害剤市場における各社の独自のポジションをより深く理解するために、ブルートン型チロシンキナーゼ（BTK）阻害剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のブルートン型チロシンキナーゼ（BTK）阻害剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ブルートン型チロシンキナーゼ（BTK）阻害剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。ブルートン型チロシンキナーゼ（BTK）阻害剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ブルートン型チロシンキナーゼ（BTK）阻害剤のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ブルートン型チロシンキナーゼ（BTK）阻害剤の世界主要メーカーとしては、BeiGene, Ltd.、 Merck KGaA、 Principia Biopharma Inc.、 ACEA Biosciences, Inc.、 Bristol- Myers Squibb Company、 Adolph Kiefer & Associates, Llc、 Johnson & Johnson Services, Inc、 ACEA Biosciences Inc.、 Aptose Biosciences Inc.、 Eternity Bioscience Inc.、 Takeda Pharmaceuticals Industries Ltd.、 Gilead Sciences Inc.、 AbbVie Inc.などを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のブルートン型チロシンキナーゼ（BTK）阻害剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではブルートン型チロシンキナーゼ（BTK）阻害剤市場をセグメンテーションし、種類別 (インブルヴィカ、カルケンス、ブルキンサ)、用途別 (オンライン販売、オフライン販売)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：インブルヴィカ、カルケンス、ブルキンサ

・用途別区分：オンライン販売、オフライン販売

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のブルートン型チロシンキナーゼ（BTK）阻害剤市場の10年間の市場状況・展望は？
・世界および地域別に見たブルートン型チロシンキナーゼ（BTK）阻害剤市場成長の要因は何か？
・ブルートン型チロシンキナーゼ（BTK）阻害剤の市場機会はエンドマーケットの規模によってどのように変化するのか？
・ブルートン型チロシンキナーゼ（BTK）阻害剤のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：ブルートン型チロシンキナーゼ（BTK）阻害剤の年間販売量2018-2029、地域別現状・将来分析
・ブルートン型チロシンキナーゼ（BTK）阻害剤の種類別セグメント：インブルヴィカ、カルケンス、ブルキンサ
・ブルートン型チロシンキナーゼ（BTK）阻害剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・ブルートン型チロシンキナーゼ（BTK）阻害剤の用途別セグメント：オンライン販売、オフライン販売
・ブルートン型チロシンキナーゼ（BTK）阻害剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のブルートン型チロシンキナーゼ（BTK）阻害剤市場
・企業別のグローバルブルートン型チロシンキナーゼ（BTK）阻害剤市場データ：2018-2023年の年間販売量、市場シェア
・企業別のブルートン型チロシンキナーゼ（BTK）阻害剤の年間売上：2018-2023年の売上、市場シェア
・企業別のブルートン型チロシンキナーゼ（BTK）阻害剤販売価格
・主要企業のブルートン型チロシンキナーゼ（BTK）阻害剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ブルートン型チロシンキナーゼ（BTK）阻害剤の地域別レビュー
・地域別のブルートン型チロシンキナーゼ（BTK）阻害剤市場規模2018-2023：年間販売量、売上
・主要国別のブルートン型チロシンキナーゼ（BTK）阻害剤市場規模2018-2023：年間販売量、売上
・南北アメリカのブルートン型チロシンキナーゼ（BTK）阻害剤販売の成長
・アジア太平洋のブルートン型チロシンキナーゼ（BTK）阻害剤販売の成長
・ヨーロッパのブルートン型チロシンキナーゼ（BTK）阻害剤販売の成長
・中東・アフリカのブルートン型チロシンキナーゼ（BTK）阻害剤販売の成長

南北アメリカ市場
・南北アメリカの国別のブルートン型チロシンキナーゼ（BTK）阻害剤販売量、売上（2018-2023）
・南北アメリカのブルートン型チロシンキナーゼ（BTK）阻害剤の種類別販売量
・南北アメリカのブルートン型チロシンキナーゼ（BTK）阻害剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のブルートン型チロシンキナーゼ（BTK）阻害剤販売量、売上（2018-2023）
・アジア太平洋のブルートン型チロシンキナーゼ（BTK）阻害剤の種類別販売量
・アジア太平洋のブルートン型チロシンキナーゼ（BTK）阻害剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のブルートン型チロシンキナーゼ（BTK）阻害剤販売量、売上（2018-2023）
・ヨーロッパのブルートン型チロシンキナーゼ（BTK）阻害剤の種類別販売量
・ヨーロッパのブルートン型チロシンキナーゼ（BTK）阻害剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のブルートン型チロシンキナーゼ（BTK）阻害剤販売量、売上（2018-2023）
・中東・アフリカのブルートン型チロシンキナーゼ（BTK）阻害剤の種類別販売量
・中東・アフリカのブルートン型チロシンキナーゼ（BTK）阻害剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ブルートン型チロシンキナーゼ（BTK）阻害剤の製造コスト構造分析
・ブルートン型チロシンキナーゼ（BTK）阻害剤の製造プロセス分析
・ブルートン型チロシンキナーゼ（BTK）阻害剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・ブルートン型チロシンキナーゼ（BTK）阻害剤の主要なグローバル販売業者
・ブルートン型チロシンキナーゼ（BTK）阻害剤の主要なグローバル顧客

地域別のブルートン型チロシンキナーゼ（BTK）阻害剤市場予測レビュー
・地域別のブルートン型チロシンキナーゼ（BTK）阻害剤市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ブルートン型チロシンキナーゼ（BTK）阻害剤の種類別市場規模予測
・ブルートン型チロシンキナーゼ（BTK）阻害剤の用途別市場規模予測

主要企業分析
BeiGene, Ltd.、 Merck KGaA、 Principia Biopharma Inc.、 ACEA Biosciences, Inc.、 Bristol- Myers Squibb Company、 Adolph Kiefer & Associates, Llc、 Johnson & Johnson Services, Inc、 ACEA Biosciences Inc.、 Aptose Biosciences Inc.、 Eternity Bioscience Inc.、 Takeda Pharmaceuticals Industries Ltd.、 Gilead Sciences Inc.、 AbbVie Inc.
・企業情報
・ブルートン型チロシンキナーゼ（BTK）阻害剤製品
・ブルートン型チロシンキナーゼ（BTK）阻害剤販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Bruton’s Tyrosine Kinase (BTK) Inhibitors market size is projected to grow from US$ 9489 million in 2022 to US$ 16580 million in 2029; it is expected to grow at a CAGR of 8.3% from 2023 to 2029.
United States market for Bruton’s Tyrosine Kinase (BTK) Inhibitors is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Bruton’s Tyrosine Kinase (BTK) Inhibitors is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Bruton’s Tyrosine Kinase (BTK) Inhibitors is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Bruton’s Tyrosine Kinase (BTK) Inhibitors players cover BeiGene, Ltd., Merck KGaA, Principia Biopharma Inc., ACEA Biosciences, Inc., Bristol- Myers Squibb Company, Adolph Kiefer & Associates, Llc, Johnson & Johnson Services, Inc, ACEA Biosciences Inc. and Aptose Biosciences Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Bruton’s Tyrosine Kinase (BTK) Inhibitors Industry Forecast” looks at past sales and reviews total world Bruton’s Tyrosine Kinase (BTK) Inhibitors sales in 2022, providing a comprehensive analysis by region and market sector of projected Bruton’s Tyrosine Kinase (BTK) Inhibitors sales for 2023 through 2029. With Bruton’s Tyrosine Kinase (BTK) Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bruton’s Tyrosine Kinase (BTK) Inhibitors industry.
This Insight Report provides a comprehensive analysis of the global Bruton’s Tyrosine Kinase (BTK) Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bruton’s Tyrosine Kinase (BTK) Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bruton’s Tyrosine Kinase (BTK) Inhibitors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bruton’s Tyrosine Kinase (BTK) Inhibitors and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bruton’s Tyrosine Kinase (BTK) Inhibitors.
This report presents a comprehensive overview, market shares, and growth opportunities of Bruton’s Tyrosine Kinase (BTK) Inhibitors market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Imbruvica
Calquence
Brukinsa
Segmentation by application
Online Sales
Offline Sales
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
BeiGene, Ltd.
Merck KGaA
Principia Biopharma Inc.
ACEA Biosciences, Inc.
Bristol- Myers Squibb Company
Adolph Kiefer & Associates, Llc
Johnson & Johnson Services, Inc
ACEA Biosciences Inc.
Aptose Biosciences Inc.
Eternity Bioscience Inc.
Takeda Pharmaceuticals Industries Ltd.
Gilead Sciences Inc.
AbbVie Inc.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bruton’s Tyrosine Kinase (BTK) Inhibitors market?
What factors are driving Bruton’s Tyrosine Kinase (BTK) Inhibitors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bruton’s Tyrosine Kinase (BTK) Inhibitors market opportunities vary by end market size?
How does Bruton’s Tyrosine Kinase (BTK) Inhibitors break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Bruton’s Tyrosine Kinase (BTK) Inhibitors by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Bruton’s Tyrosine Kinase (BTK) Inhibitors by Country/Region, 2018, 2022 & 2029
2.2 Bruton’s Tyrosine Kinase (BTK) Inhibitors Segment by Type
2.2.1 Imbruvica
2.2.2 Calquence
2.2.3 Brukinsa
2.3 Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Type
2.3.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Type (2018-2023)
2.3.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue and Market Share by Type (2018-2023)
2.3.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sale Price by Type (2018-2023)
2.4 Bruton’s Tyrosine Kinase (BTK) Inhibitors Segment by Application
2.4.1 Online Sales
2.4.2 Offline Sales
2.5 Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Application
2.5.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sale Market Share by Application (2018-2023)
2.5.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue and Market Share by Application (2018-2023)
2.5.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sale Price by Application (2018-2023)
3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors by Company
3.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Breakdown Data by Company
3.1.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Annual Sales by Company (2018-2023)
3.1.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Company (2018-2023)
3.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Annual Revenue by Company (2018-2023)
3.2.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue by Company (2018-2023)
3.2.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Company (2018-2023)
3.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sale Price by Company
3.4 Key Manufacturers Bruton’s Tyrosine Kinase (BTK) Inhibitors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Location Distribution
3.4.2 Players Bruton’s Tyrosine Kinase (BTK) Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bruton’s Tyrosine Kinase (BTK) Inhibitors by Geographic Region
4.1 World Historic Bruton’s Tyrosine Kinase (BTK) Inhibitors Market Size by Geographic Region (2018-2023)
4.1.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Bruton’s Tyrosine Kinase (BTK) Inhibitors Market Size by Country/Region (2018-2023)
4.2.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Annual Sales by Country/Region (2018-2023)
4.2.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Annual Revenue by Country/Region (2018-2023)
4.3 Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Growth
4.4 APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Growth
4.5 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Growth
4.6 Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Growth
5 Americas
5.1 Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Country
5.1.1 Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Country (2018-2023)
5.1.2 Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue by Country (2018-2023)
5.2 Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Type
5.3 Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Region
6.1.1 APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Region (2018-2023)
6.1.2 APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue by Region (2018-2023)
6.2 APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Type
6.3 APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors by Country
7.1.1 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Country (2018-2023)
7.1.2 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue by Country (2018-2023)
7.2 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Type
7.3 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors by Country
8.1.1 Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Country (2018-2023)
8.1.2 Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue by Country (2018-2023)
8.2 Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Type
8.3 Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors
10.3 Manufacturing Process Analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors
10.4 Industry Chain Structure of Bruton’s Tyrosine Kinase (BTK) Inhibitors
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bruton’s Tyrosine Kinase (BTK) Inhibitors Distributors
11.3 Bruton’s Tyrosine Kinase (BTK) Inhibitors Customer
12 World Forecast Review for Bruton’s Tyrosine Kinase (BTK) Inhibitors by Geographic Region
12.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Market Size Forecast by Region
12.1.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Forecast by Region (2024-2029)
12.1.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Forecast by Type
12.7 Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Forecast by Application
13 Key Players Analysis
13.1 BeiGene, Ltd.
13.1.1 BeiGene, Ltd. Company Information
13.1.2 BeiGene, Ltd. Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
13.1.3 BeiGene, Ltd. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 BeiGene, Ltd. Main Business Overview
13.1.5 BeiGene, Ltd. Latest Developments
13.2 Merck KGaA
13.2.1 Merck KGaA Company Information
13.2.2 Merck KGaA Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
13.2.3 Merck KGaA Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck KGaA Main Business Overview
13.2.5 Merck KGaA Latest Developments
13.3 Principia Biopharma Inc.
13.3.1 Principia Biopharma Inc. Company Information
13.3.2 Principia Biopharma Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
13.3.3 Principia Biopharma Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Principia Biopharma Inc. Main Business Overview
13.3.5 Principia Biopharma Inc. Latest Developments
13.4 ACEA Biosciences, Inc.
13.4.1 ACEA Biosciences, Inc. Company Information
13.4.2 ACEA Biosciences, Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
13.4.3 ACEA Biosciences, Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 ACEA Biosciences, Inc. Main Business Overview
13.4.5 ACEA Biosciences, Inc. Latest Developments
13.5 Bristol- Myers Squibb Company
13.5.1 Bristol- Myers Squibb Company Company Information
13.5.2 Bristol- Myers Squibb Company Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
13.5.3 Bristol- Myers Squibb Company Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Bristol- Myers Squibb Company Main Business Overview
13.5.5 Bristol- Myers Squibb Company Latest Developments
13.6 Adolph Kiefer & Associates, Llc
13.6.1 Adolph Kiefer & Associates, Llc Company Information
13.6.2 Adolph Kiefer & Associates, Llc Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
13.6.3 Adolph Kiefer & Associates, Llc Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Adolph Kiefer & Associates, Llc Main Business Overview
13.6.5 Adolph Kiefer & Associates, Llc Latest Developments
13.7 Johnson & Johnson Services, Inc
13.7.1 Johnson & Johnson Services, Inc Company Information
13.7.2 Johnson & Johnson Services, Inc Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
13.7.3 Johnson & Johnson Services, Inc Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Johnson & Johnson Services, Inc Main Business Overview
13.7.5 Johnson & Johnson Services, Inc Latest Developments
13.8 ACEA Biosciences Inc.
13.8.1 ACEA Biosciences Inc. Company Information
13.8.2 ACEA Biosciences Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
13.8.3 ACEA Biosciences Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 ACEA Biosciences Inc. Main Business Overview
13.8.5 ACEA Biosciences Inc. Latest Developments
13.9 Aptose Biosciences Inc.
13.9.1 Aptose Biosciences Inc. Company Information
13.9.2 Aptose Biosciences Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
13.9.3 Aptose Biosciences Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Aptose Biosciences Inc. Main Business Overview
13.9.5 Aptose Biosciences Inc. Latest Developments
13.10 Eternity Bioscience Inc.
13.10.1 Eternity Bioscience Inc. Company Information
13.10.2 Eternity Bioscience Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
13.10.3 Eternity Bioscience Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Eternity Bioscience Inc. Main Business Overview
13.10.5 Eternity Bioscience Inc. Latest Developments
13.11 Takeda Pharmaceuticals Industries Ltd.
13.11.1 Takeda Pharmaceuticals Industries Ltd. Company Information
13.11.2 Takeda Pharmaceuticals Industries Ltd. Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
13.11.3 Takeda Pharmaceuticals Industries Ltd. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Takeda Pharmaceuticals Industries Ltd. Main Business Overview
13.11.5 Takeda Pharmaceuticals Industries Ltd. Latest Developments
13.12 Gilead Sciences Inc.
13.12.1 Gilead Sciences Inc. Company Information
13.12.2 Gilead Sciences Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
13.12.3 Gilead Sciences Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Gilead Sciences Inc. Main Business Overview
13.12.5 Gilead Sciences Inc. Latest Developments
13.13 AbbVie Inc.
13.13.1 AbbVie Inc. Company Information
13.13.2 AbbVie Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
13.13.3 AbbVie Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 AbbVie Inc. Main Business Overview
13.13.5 AbbVie Inc. Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Bruton’s Tyrosine Kinase (BTK) Inhibitors Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Bruton’s Tyrosine Kinase (BTK) Inhibitors Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Imbruvica
Table 4. Major Players of Calquence
Table 5. Major Players of Brukinsa
Table 6. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Type (2018-2023) & (K Units)
Table 7. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Type (2018-2023)
Table 8. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue by Type (2018-2023) & ($ million)
Table 9. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Type (2018-2023)
Table 10. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Application (2018-2023) & (K Units)
Table 12. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Application (2018-2023)
Table 13. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue by Application (2018-2023)
Table 14. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Application (2018-2023)
Table 15. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Company (2018-2023) & (K Units)
Table 17. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Company (2018-2023)
Table 18. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Company (2018-2023)
Table 20. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Bruton’s Tyrosine Kinase (BTK) Inhibitors Producing Area Distribution and Sales Area
Table 22. Players Bruton’s Tyrosine Kinase (BTK) Inhibitors Products Offered
Table 23. Bruton’s Tyrosine Kinase (BTK) Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share Geographic Region (2018-2023)
Table 28. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Country/Region (2018-2023)
Table 32. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Country (2018-2023) & (K Units)
Table 35. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Country (2018-2023)
Table 36. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Country (2018-2023)
Table 38. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Type (2018-2023) & (K Units)
Table 39. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Application (2018-2023) & (K Units)
Table 40. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Region (2018-2023) & (K Units)
Table 41. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Region (2018-2023)
Table 42. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Region (2018-2023)
Table 44. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Type (2018-2023) & (K Units)
Table 45. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Application (2018-2023) & (K Units)
Table 46. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Country (2018-2023) & (K Units)
Table 47. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Country (2018-2023)
Table 48. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Country (2018-2023)
Table 50. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Type (2018-2023) & (K Units)
Table 51. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Bruton’s Tyrosine Kinase (BTK) Inhibitors
Table 59. Key Market Challenges & Risks of Bruton’s Tyrosine Kinase (BTK) Inhibitors
Table 60. Key Industry Trends of Bruton’s Tyrosine Kinase (BTK) Inhibitors
Table 61. Bruton’s Tyrosine Kinase (BTK) Inhibitors Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Bruton’s Tyrosine Kinase (BTK) Inhibitors Distributors List
Table 64. Bruton’s Tyrosine Kinase (BTK) Inhibitors Customer List
Table 65. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. BeiGene, Ltd. Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 80. BeiGene, Ltd. Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
Table 81. BeiGene, Ltd. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. BeiGene, Ltd. Main Business
Table 83. BeiGene, Ltd. Latest Developments
Table 84. Merck KGaA Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck KGaA Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
Table 86. Merck KGaA Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Merck KGaA Main Business
Table 88. Merck KGaA Latest Developments
Table 89. Principia Biopharma Inc. Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 90. Principia Biopharma Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
Table 91. Principia Biopharma Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Principia Biopharma Inc. Main Business
Table 93. Principia Biopharma Inc. Latest Developments
Table 94. ACEA Biosciences, Inc. Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 95. ACEA Biosciences, Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
Table 96. ACEA Biosciences, Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. ACEA Biosciences, Inc. Main Business
Table 98. ACEA Biosciences, Inc. Latest Developments
Table 99. Bristol- Myers Squibb Company Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 100. Bristol- Myers Squibb Company Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
Table 101. Bristol- Myers Squibb Company Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Bristol- Myers Squibb Company Main Business
Table 103. Bristol- Myers Squibb Company Latest Developments
Table 104. Adolph Kiefer & Associates, Llc Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 105. Adolph Kiefer & Associates, Llc Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
Table 106. Adolph Kiefer & Associates, Llc Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Adolph Kiefer & Associates, Llc Main Business
Table 108. Adolph Kiefer & Associates, Llc Latest Developments
Table 109. Johnson & Johnson Services, Inc Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 110. Johnson & Johnson Services, Inc Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
Table 111. Johnson & Johnson Services, Inc Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Johnson & Johnson Services, Inc Main Business
Table 113. Johnson & Johnson Services, Inc Latest Developments
Table 114. ACEA Biosciences Inc. Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 115. ACEA Biosciences Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
Table 116. ACEA Biosciences Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. ACEA Biosciences Inc. Main Business
Table 118. ACEA Biosciences Inc. Latest Developments
Table 119. Aptose Biosciences Inc. Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 120. Aptose Biosciences Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
Table 121. Aptose Biosciences Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Aptose Biosciences Inc. Main Business
Table 123. Aptose Biosciences Inc. Latest Developments
Table 124. Eternity Bioscience Inc. Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 125. Eternity Bioscience Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
Table 126. Eternity Bioscience Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Eternity Bioscience Inc. Main Business
Table 128. Eternity Bioscience Inc. Latest Developments
Table 129. Takeda Pharmaceuticals Industries Ltd. Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 130. Takeda Pharmaceuticals Industries Ltd. Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
Table 131. Takeda Pharmaceuticals Industries Ltd. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Takeda Pharmaceuticals Industries Ltd. Main Business
Table 133. Takeda Pharmaceuticals Industries Ltd. Latest Developments
Table 134. Gilead Sciences Inc. Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 135. Gilead Sciences Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
Table 136. Gilead Sciences Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Gilead Sciences Inc. Main Business
Table 138. Gilead Sciences Inc. Latest Developments
Table 139. AbbVie Inc. Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 140. AbbVie Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Product Portfolios and Specifications
Table 141. AbbVie Inc. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. AbbVie Inc. Main Business
Table 143. AbbVie Inc. Latest Developments
List of Figures
Figure 1. Picture of Bruton’s Tyrosine Kinase (BTK) Inhibitors
Figure 2. Bruton’s Tyrosine Kinase (BTK) Inhibitors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Imbruvica
Figure 10. Product Picture of Calquence
Figure 11. Product Picture of Brukinsa
Figure 12. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Type in 2022
Figure 13. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Type (2018-2023)
Figure 14. Bruton’s Tyrosine Kinase (BTK) Inhibitors Consumed in Online Sales
Figure 15. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Market: Online Sales (2018-2023) & (K Units)
Figure 16. Bruton’s Tyrosine Kinase (BTK) Inhibitors Consumed in Offline Sales
Figure 17. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Market: Offline Sales (2018-2023) & (K Units)
Figure 18. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Application (2022)
Figure 19. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Application in 2022
Figure 20. Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market by Company in 2022 (K Units)
Figure 21. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Company in 2022
Figure 22. Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Company in 2022
Figure 24. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales 2018-2023 (K Units)
Figure 27. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue 2018-2023 ($ Millions)
Figure 28. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales 2018-2023 (K Units)
Figure 29. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue 2018-2023 ($ Millions)
Figure 30. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales 2018-2023 (K Units)
Figure 31. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue 2018-2023 ($ Millions)
Figure 34. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Country in 2022
Figure 35. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Country in 2022
Figure 36. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Type (2018-2023)
Figure 37. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Application (2018-2023)
Figure 38. United States Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Region in 2022
Figure 43. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Regions in 2022
Figure 44. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Type (2018-2023)
Figure 45. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Application (2018-2023)
Figure 46. China Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Country in 2022
Figure 54. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Country in 2022
Figure 55. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Type (2018-2023)
Figure 56. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Application (2018-2023)
Figure 57. Germany Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Application (2018-2023)
Figure 66. Egypt Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors in 2022
Figure 72. Manufacturing Process Analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors
Figure 73. Industry Chain Structure of Bruton’s Tyrosine Kinase (BTK) Inhibitors
Figure 74. Channels of Distribution
Figure 75. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Forecast by Region (2024-2029)
Figure 76. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のブルートン型チロシンキナーゼ（BTK）阻害剤市場予測 2023年-2029年] (コード：LP23DC06286)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のブルートン型チロシンキナーゼ（BTK）阻害剤市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のPDE4阻害剤市場予測 2023年-2029年
  • 脾臓チロシンキナーゼ(Syk)阻害剤治療薬の世界市場インサイト・予測（～2028年）
  • 世界のAGK抗体市場予測 2023年-2029年
  • 世界の迅速診断試薬用充填剤市場予測 2023年-2029年
  • 世界のプロカルバジン市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆